Effectiveness of BenZalkonium Chloride Gel as Vaginal Contraceptive: a Multicentric Randomized Controlled Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Healthy
Interventions
DRUG

a novel Benzalkonium Chloride (BZK) contraceptive gel

insert 1 piece of the gel (containing 18mg BZK) into vagina before every coital act.

DRUG

LELEMI® contraceptive gel containing 50mg nonoxynol-9

insert 1 piece ofLELEMI® contraceptive gel within half an hour before every coital act

Trial Locations (3)

Unknown

Gynecology and Obstetrics Hospital of Fudan University, Shanghai

International Peace Maternity and Child Care Center, Shanghai

Shanghai No. 1 Maternity and Child Care Center, Shanghai

All Listed Sponsors
collaborator

Shanghai Municipal Commission of Health and Family Planning

OTHER

collaborator

Fudan University

OTHER

collaborator

International Peace Maternity and Child Health Hospital

OTHER

collaborator

Shanghai No. 1 Maternity and Child Care Center

UNKNOWN

collaborator

Chang Jiang Bio-pharmaceutical Co., Ltd.

INDUSTRY

lead

Shanghai Institute of Planned Parenthood Research

OTHER_GOV

NCT00692952 - Effectiveness of BenZalkonium Chloride Gel as Vaginal Contraceptive: a Multicentric Randomized Controlled Trial | Biotech Hunter | Biotech Hunter